MV Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21K | Sell |
40
-35
| -47% | -$18.4K | ﹤0.01% | 434 |
|
|
2025
Q1 | $47.6K | Sell |
75
-5
| -6% | -$3.17K | 0.01% | 309 |
|
|
2024
Q4 | $57K | Sell |
80
-7
| -8% | -$4.99K | 0.01% | 283 |
|
|
2024
Q3 | $91.5K | Buy |
87
+1
| +1% | +$1.05K | 0.01% | 244 |
|
|
2024
Q2 | $90.4K | Buy |
86
+7
| +9% | +$7.36K | 0.01% | 240 |
|
|
2024
Q1 | $76K | Sell |
79
-4
| -5% | -$3.85K | 0.01% | 260 |
|
|
2023
Q4 | $72.9K | Buy |
83
+8
| +11% | +$7.03K | 0.01% | 260 |
|
|
2023
Q3 | $61.7K | Buy |
75
+5
| +7% | +$4.12K | 0.01% | 267 |
|
|
2023
Q2 | $50.3K | Hold |
70
| – | – | 0.01% | 295 |
|
|
2023
Q1 | $57.5K | Buy |
70
+8
| +13% | +$6.57K | 0.01% | 263 |
|
|
2022
Q4 | $44.7K | Buy |
62
+3
| +5% | +$2.16K | 0.01% | 236 |
|
|
2022
Q3 | $41K | Buy |
59
+7
| +13% | +$4.86K | 0.01% | 240 |
|
|
2022
Q2 | $31K | Buy |
52
+16
| +44% | +$9.54K | 0.01% | 269 |
|
|
2022
Q1 | $25K | Buy |
36
+4
| +13% | +$2.78K | ﹤0.01% | 306 |
|
|
2021
Q4 | $20K | Sell |
32
-2
| -6% | -$1.25K | ﹤0.01% | 324 |
|
|
2021
Q3 | $21K | Buy |
34
+14
| +70% | +$8.65K | ﹤0.01% | 305 |
|
|
2021
Q2 | $11K | Buy |
20
+17
| +567% | +$9.35K | ﹤0.01% | 354 |
|
|
2021
Q1 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 420 |
|